City Therapeutics, Inc.
CTY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002143850
In the last 90 days, City Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Holders of 5% or more of CTY
Holders whose latest Schedule 13D or 13G filing reports 5% or more of City Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| ARCH Venture Fund XII, L.P. | 13D | 25.60%13.7M shares | New | Oct 26, 20261 filing | Oct 26, 2026 | SEC |
| FMR LLC | 13G | 14.00%7.03M shares | New | Nov 6, 20261 filing | Nov 6, 2026 | SEC |
| Invus Global Management, LLC | 13G | 8.10%4.34M shares | New | Oct 22, 20261 filing | Oct 22, 2026 | SEC |
| Viking Global Investors LPSuperinvestorViking Global Investors | 13G | 7.00%3.73M shares | New | Oct 26, 20261 filing | Oct 26, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on City Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 6, 20269:46 AM ET | FMR LLCand 1 other | 13G | 14.00%7.03M shares | New | Oct 30, 2026 | SEC |
| Oct 26, 20264:34 PM ET | ARCH Venture Fund XII, L.P.and 6 others | 13D | 25.60%13.7M shares | New | Oct 19, 2026 | SEC |
| Oct 26, 20264:25 PM ET | Viking Global Investors LPand 9 othersSuperinvestorViking Global Investors | 13G | 7.00%3.73M shares | New | Oct 19, 2026 | SEC |
| Oct 22, 20261:15 PM ET | Invus Global Management, LLCand 7 others | 13G | 8.10%4.34M shares | New | Oct 16, 2026 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell City Therapeutics, Inc. shares.
No Form 144 notices for City Therapeutics, Inc. are on file.